Portfolio Analysis in Washington.

A patent portfolio analysis Washington in-house teams and federal contractors can act on treats the capital for what it is — the administrative and appellate seat of U.S. patent law. Washington, D.C. is where the U.S. Court of Appeals for the Federal Circuit hears every patent appeal in the country, where the U.S. International Trade Commission runs its Section 337 exclusion-order docket, and where the government-contracting rules that decide who owns a federally funded invention are enforced. Just across the Potomac in Alexandria sit the USPTO and its Patent Trial and Appeal Board. PerspireIP builds portfolio studies for the R&D leaders, IP counsel and contractor legal teams who work in that environment.

The work is landscape, gap, strength and valuation analysis — not litigation. It is the diligence behind a defense-sector acquisition in Arlington, the government-rights schedule a contractor needs before a proposal, and the maintenance-fee decision that keeps a large federally funded portfolio from quietly overspending at the USPTO year after year.

Why a patent portfolio analysis Washington contractors trust starts with government rights

In most cities a portfolio review starts with the technology or the transaction. In Washington it starts with a question no other market asks first: who actually owns the invention. The capital’s economy runs on federal money — procurement, grants and cooperative agreements — and any invention conceived or first reduced to practice under that funding is a “subject invention” governed by the Bayh-Dole Act and the patent-rights clauses of the Federal Acquisition Regulation.

That changes what a study has to verify. A contractor may elect to retain title under Bayh-Dole, but only if it disclosed the invention on time, elected title within the statutory windows and filed accordingly — and even then the government keeps a nonexclusive, worldwide, royalty-free license to practice the invention for its own purposes, plus march-in rights in defined circumstances. A patent portfolio analysis Washington owners rely on maps those encumbrances asset by asset, because a patent the government can already use royalty-free is worth less in a deal than a clean private title.

• Subject-invention audit — which assets arose under federal funding and carry Bayh-Dole obligations
• Government-license and march-in exposure — where the government holds a royalty-free license or retained march-in rights
• FAR / DFARS patent-rights clauses — confirming disclosure, election-of-title and confirmatory-license compliance
• Title and chain-of-ownership — a clean provenance record a buyer or contracting officer can trust

The Federal Circuit on your doorstep: one court, one body of precedent

Every U.S. patent appeal — whether it comes from a district court, the PTAB or the ITC — is decided by a single court, and it sits in Washington. The U.S. Court of Appeals for the Federal Circuit occupies the Howard T. Markey National Courts Building at 717 Madison Place NW, on the east side of Lafayette Square across from the White House. Its nationwide jurisdiction over patents means the law on claim construction, obviousness and eligibility is uniform across the country.

For a portfolio owner that concentration is a gift: a Washington estate can be graded against one coherent line of precedent rather than a patchwork of regional rules. When we score claim strength we test each significant asset against how the Federal Circuit currently reads Section 101 eligibility, obviousness under KSR and claim construction under Phillips and Nautilus — the same standards a buyer’s counsel or an IPR panel will apply.

It also means proximity has real value here. Contractors, agencies and IP boutiques cluster in the District precisely because the court that will ultimately decide their patents’ fate is a few blocks away, and the bar that argues before it is local. We build portfolio analysis that reads each asset the way that court would.

PTAB across the Potomac and IPR as a strength test

Strength is not how many claims you hold — it is how many survive a challenge. Roughly six miles from the Federal Circuit, at the USPTO’s Madison Building, 600 Dulany Street in Alexandria, Virginia, the Patent Trial and Appeal Board hears inter partes review: the administrative proceeding in which a challenger asks to cancel claims for lack of novelty or obviousness over patents and printed publications.

The economics of IPR are why it belongs in every portfolio grade. The Board institutes only where a petitioner shows a reasonable likelihood of prevailing on at least one claim, then decides on a preponderance of the evidence — a lower bar than the clear-and-convincing standard a district court applies — with a final written decision due within twelve months of institution. That makes IPR faster, cheaper and more dangerous to a patent than court.

So we stress-test each meaningful asset for its IPR exposure: how crowded is the prior art, how broad are the independent claims, how vulnerable is the family to an obviousness combination. A patent that would not survive an IPR is worth less in a deal and hazardous to assert. Better to know before a challenger does than to learn it in a data room.

ITC Section 337: exclusion orders as portfolio leverage and liability

Washington hosts a forum no other city does. The U.S. International Trade Commission runs Section 337 investigations into unfair imports — most often patent infringement by imported goods — and its remedies bite in a way district-court damages do not. The ITC cannot award money; it issues exclusion orders that direct U.S. Customs to stop infringing imports at the border, and cease-and-desist orders against named importers.

Those orders come in two flavours that every portfolio holding import-relevant patents should be graded against. A limited exclusion order blocks the named respondents’ products; a general exclusion order blocks all infringing articles regardless of who imports them — a powerful, market-wide remedy. Investigations also move fast, typically resolving in 16 to 18 months, and require a domestic-industry showing rather than mere ownership.

For a Washington-area technology or hardware company the ITC is a two-sided fact in a patent portfolio analysis. Which of your patents could support a Section 337 exclusion order against an offshore competitor — an offensive asset that most valuations miss — and which third-party patents could get your imported products excluded? We map both, so the estate’s border-enforcement leverage and exposure are on the page, not a surprise.

What Washington’s defense, govtech, cyber and biotech portfolios look like

The capital region’s patent base mirrors its economy, and that economy is federal. The Northern Virginia and Maryland suburbs hold the densest concentration of defense and aerospace contractors, systems integrators and cybersecurity firms in the United States — Fairfax and Arlington counties alone capture more federal procurement dollars than anywhere else in the country. Their portfolios are heavy on software, signals, sensing, encryption and autonomy inventions, much of it developed under government funding and therefore laced with Bayh-Dole obligations.

• Defense, aerospace and govtech — sensing, autonomy, secure comms and systems patents, frequently subject-inventions under federal contracts with government-use licenses attached
• Cybersecurity — encryption, intrusion-detection and identity patents, software-heavy and exposed to Section 101 eligibility questions
• Biotech and life sciences — anchored by the NIH campus in Bethesda and the FDA in Silver Spring; composition, diagnostic and platform families where a single patent can carry a product, and many arise from federally funded research
• Policy, standards and telecom — the standard-setting and think-tank base makes standard-essential-patent and FRAND exposure a live portfolio question

Each estate hides its value in a different place. A defense contractor’s portfolio may be constrained by government-use licenses no acquirer can strip; a cyber estate is a thicket of software claims whose strength is collective and eligibility-sensitive; an NIH-spun biotech asset may live or die on one composition patent and its funding history. A patent portfolio analysis Washington owners depend on reads each estate on its own terms rather than counting patents.

Pruning USPTO maintenance-fee spend across a federally funded estate

The single fastest return a portfolio review delivers is usually a cut, not a filing. U.S. patents carry maintenance fees at three fixed points after grant — 3.5, 7.5 and 11.5 years — and the fees escalate steeply. For a large entity the schedule effective 19 January 2025 is $1,600, then $3,600, then $7,400, with a $540 surcharge in the six-month grace period before a patent lapses. Small entities pay 60% less and micro entities 80% less, but the escalation curve is identical.

Across a large research-driven estate that is a six- or seven-figure annual annuity bill, much of it spent on patents that no longer read on a live product, contract vehicle or competitor. A pruning analysis scores each asset before its next window against three tests: does it still cover a shipping product or a program of record, does it block a competitor, and would a buyer or licensee pay for it.

For a federally funded portfolio there is a fourth test unique to Washington: abandoning a subject invention can trigger notice obligations to the funding agency, which may itself elect to take title. We flag those assets so a pruning decision does not breach a Bayh-Dole clause. For most Washington portfolio owners the exercise pays for itself many times over at the first 11.5-year decision it informs.

Landscape and white-space work, plus where Washington disputes actually land

The offensive side of portfolio work is finding what you do not yet own. A landscape maps the patents held by you and your competitors across a technology area; a gap or white-space analysis then shows where protectable, commercially useful inventions sit unclaimed — the ground your R&D leaders should be filing into before a rival, or a foreign state actor’s national champion, gets there first. In the defense and cyber space that white-space read is also a competitive-intelligence tool.

Forum matters too. Patent suits in the District are filed in the U.S. District Court for the District of Columbia at the E. Barrett Prettyman Courthouse, 333 Constitution Avenue NW. In practice, though, few high-stakes patent trials land here: under the Supreme Court’s TC Heartland venue rule, most cases gravitate to the Eastern and Western Districts of Texas and the District of Delaware, where many companies are incorporated or maintain a regular place of business.

The exception is the government itself. A patentee whose invention is used by or for the United States without a license cannot sue the government for infringement in a normal court; the exclusive remedy is a claim for reasonable compensation under 28 U.S.C. 1498 in the Court of Federal Claims, also seated in Washington. For any contractor or supplier, that statute is a core portfolio fact — both a shield when you build for the government and a limit on what you can recover when the government uses your patent.

How PerspireIP builds a Washington portfolio analysis you can act on

Every engagement follows the same disciplined path, scaled to whether you are prepping a data room, defending a budget, clearing a proposal or planning next year’s filings. We inventory the portfolio, verify legal status and title, trace federal-funding provenance, map each asset to products, programs and competitors, grade strength and IPR exposure, weigh ITC leverage, and price the estate for the transaction or decision that prompted the review.

• Full inventory with legal-status, term and maintenance-fee timeline for every asset
• Bayh-Dole subject-invention audit and government-license / march-in exposure map
• Product- and program-to-patent coverage mapping with a claim-strength score
• PTAB / IPR-risk grading of the significant assets against the prior art
• ITC Section 337 leverage-and-exposure read for import-relevant patents
• Landscape, gap and white-space maps, with SEP and FRAND exposure where relevant
• Maintenance-fee pruning tied to the next 3.5, 7.5 and 11.5-year windows, cleared against funding obligations

We work alongside your in-house IP team, corporate-development group or outside counsel as a specialist analysis partner, deliver to your deal, proposal or budget calendar, and keep every engagement confidential. Whether you need a one-time diligence study before a defense-sector acquisition, an annual portfolio health check for the board, or an ongoing pruning and landscaping program, we scale to fit. Send us the assignee name or a patent list and we will scope a patent portfolio analysis Washington project within one business day.

IP Landscape & Resources in Washington

Key intellectual-property authorities and venues relevant to Washington:

• United States Patent and Trademark Office (USPTO) — grants U.S. patents from its Alexandria, Virginia headquarters and sets the maintenance-fee schedule due at 3.5, 7.5 and 11.5 years that drives portfolio pruning
• U.S. Court of Appeals for the Federal Circuit — the single appellate court for all U.S. patent appeals, seated at 717 Madison Place NW on Lafayette Square in Washington, giving portfolios one uniform body of precedent
• U.S. International Trade Commission (ITC) — runs Section 337 investigations from Washington and issues limited and general exclusion orders that stop infringing imports at the border
• U.S. District Court for the District of Columbia — the federal trial court for patent suits filed in the District, at the E. Barrett Prettyman Courthouse on Constitution Avenue

Request a Patent Portfolio Analysis in Washington DC

Explore related PerspireIP services: Patent Portfolio Analysis services · IP services in the United States · patent invalidation · prior art search · patent landscape analysis.

Frequently Asked Questions